ICON provides outsourced development and commercialization services globally. The company specializes in clinical development programs from compound selection to Phase I-IV studies. Services include clinical trial management, consulting, contract staffing, data solutions, and site access. Additionally, ICON offers laboratory services, including bionanalytical and central lab services. The company also provides adaptive trials, cardiac safety solutions, and real-world intelligence. ICON serves pharmaceutical, biotechnology, medical device industries, government, and public health organizations. Headquartered in Dublin, Ireland since 1990.
Indicator | Value |
---|---|
PER | 18.2 |
EV/EBITDA | 10.3 |
Price/Free Cash Flow' | 12.9 |
ROIC | 9.9% |
Net Debt/EBITDA | 1.7 |